Valacyclovir
- Product NDC
- 50090-7270
- 11-digit product format
- 500907270
- Labeler code
- 50090
- Product ID
- 50090-7270_50117a81-fa76-4abc-bb77-1d30f2274a20
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valacyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA209553
- Marketing category
- ANDA
- Marketing start
- 2023-02-14
- Substance
- VALACYCLOVIR HYDROCHLORIDE
- Active strength
- 1000 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| G447S0T1VC | VALACYCLOVIR HYDROCHLORIDE | 124832-27-5 | VALACYCLOVIR HYDROCHLORIDE |
| MZ1IW7Q79D | VALACYCLOVIR | 124832-26-4 | Valacyclovir |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7270-0 | 50090727000 | 15 TABLET in 1 BOTTLE (50090-7270-0) | 15 tablet | 2024-10-08 | No | No | Historical |
| 50090-7270-1 | 50090727001 | 21 TABLET in 1 BOTTLE (50090-7270-1) | 21 tablet | 2024-10-08 | No | No | Historical |
| 50090-7270-2 | 50090727002 | 30 TABLET in 1 BOTTLE (50090-7270-2) | 30 tablet | 2024-10-08 | No | No | Historical |
| 50090-7270-3 | 50090727003 | 90 TABLET in 1 BOTTLE (50090-7270-3) | 90 tablet | 2024-10-08 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Valacyclovir | A-S Medication Solutions | 2024-10-10 | HUMAN PRESCRIPTION DRUG LABEL | 1 |